Client News

Formycon Reports on a Successful Financial Year 2024 with Strong Operational Progress and Continuous Strengthening of its Market Position

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

Secarna Pharmaceuticals to Present Positive New Data on Antisense Oligonucleotide SECN-15 Targeting NRP1 as Monotherapy and in Combination with Immune Checkpoint Inhibitors at AACR

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Newron Proposes Renowned Biopharma Company Founder and Entrepreneur Dr. Chris Martin for Election as Independent Chairman

Galimedix Therapeutics to Present Positive Pre-Clinical Data with GAL-201 on Alzheimer’s Disease AD/PD™ 2025 Conference

Advanced Medical Balloons Announces its New Hygh-Tec Odor SolutionTM Product, Broadening its Catheter Portfolio

Abivax Announces Full Year 2024 Financial Result

Formycon Invites to Conference Call on the Results of the Financial Year 2024 and Announces Participation in International Investor Conferences in the 2nd Quarter of 2025